Hepatic hemangioma laboratory findings

Hepatic hemangioma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hepatic Hemangioma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hepatic hemangioma laboratory findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hepatic hemangioma laboratory findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hepatic hemangioma laboratory findings
CDC on Hepatic hemangioma laboratory findings
Hepatic hemangioma laboratory findings in the news
Blogs on Hepatic hemangioma laboratory findings
Directions to Hospitals Treating Hepatic hemangioma
Risk calculators and risk factors for Hepatic hemangioma laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]

Overview

Some patients with hepatic hemangioma may have elevated concentration of transaminases, bilirubin, and alkaline phosphatase even in asymptomatic cases.

Hepatic hemangioma laboratory findings

Some patients with hepatic hemangioma may have elevated concentration of transaminases, bilirubin, and alkaline phosphatase even in asymptomatic cases.